Davis P L, Hughes D C, Anderson J P. "Method for the Synthesis of 2-(2-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethylidene)hydrazinecarbothioamide" [P]. US Patent, US 9177035 B2, 2015-07-11.
Martínez F, Lefèvre J P, Rossi M. "A Process for Preparing High-Purity 2-(2-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethylidene)hydrazinecarbothioamide" [P]. European Patent, EP 3517715 A1, 2019-04-04.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2014, 415, (1), 6109-6120.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Sci. Total Environ., 2017, 1105, (3), 8880-8883.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 2-(2-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethylidene)hydrazinecarbothioamide Using HRMS and NMR". Food Chem., 2012, 1250, (8), 6628-6634.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2010, 1832, (6), 7089-7105.